CVRx (CVRX) Shares Outstanding (Diluted Average) (2021 - 2026)

CVRx (CVRX) recorded quarterly Shares Outstanding (Diluted Average) of $26.4 million in Q1 2026, up 1.04% quarter-over-quarter from $26.1 million in Q4 2025, and up 1.85% on a YoY basis from $25.9 million in Q1 2025.

CVRx (CVRX) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends

CVRx's Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $26.4 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 1.85% year-over-year to $26.4 million; the TTM figure through Mar 2026 stood at $26.4 million (up 1.85% YoY), while the FY2025 annual figure was $26.1 million, up 15.44% from the prior year.
  • Shares Outstanding (Diluted Average) was $26.4 million for Q1 2026 at CVRx, up from $26.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $26.4 million in Q1 2026 to a low of $20.5 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $22.5 million across 5 years, with a median of $21.2 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) surged 5570.85% in 2022, then grew 1.01% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $20.5 million in 2022, then gained by 1.08% to $20.8 million in 2023, then rose by 8.87% to $22.6 million in 2024, then rose by 15.44% to $26.1 million in 2025, then grew by 1.04% to $26.4 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $26.4 million (Q1 2026), $26.1 million (Q4 2025), and $26.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.75 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 386.50 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.29 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.50 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 580.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 393.60 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 457.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 CVRx 130.46 Mn 58.16 Mn 12.88 Mn 26.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 26.36 Mn
Dec 31, 2025 26.08 Mn
Sep 30, 2025 26.04 Mn
Jun 30, 2025 25.97 Mn
Mar 31, 2025 25.88 Mn
Dec 31, 2024 22.60 Mn
Sep 30, 2024 21.88 Mn
Jun 30, 2024 21.43 Mn
Mar 31, 2024 21.23 Mn
Dec 31, 2023 20.75 Mn
Sep 30, 2023 20.80 Mn
Jun 30, 2023 20.71 Mn
Mar 31, 2023 20.69 Mn
Dec 31, 2022 20.53 Mn
Sep 30, 2022 20.58 Mn
Jun 30, 2022 20.51 Mn
Mar 31, 2022 20.45 Mn
Dec 31, 2021 10.36 Mn
Sep 30, 2021 20.13 Mn
Jun 30, 2021 366,066.00